SHANGHAI - During the first half of 2011, China posted strong export and import growth in its medical products, which include pharmaceutical, active pharmaceutical ingredients, medical devices and traditional Chinese medicines, according to an Aug. 11 report from China's Chamber of Commerce
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Company surprises investors with Jørgensen's exit but insists its strategy will not change.
The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.
Recent moves in the industry include changes at the top at Akamis Bio, Innospera Pharma & Ispen, plus Astellas Korea appoints an ex-Novartis Korea executive.
